SAFEGUARD SCIENTIFICS TO HOST A VIRTUAL DISCUSSION WITH INFOBIONIC
Safeguard Scientifics (NYSE: SFE) will host a virtual discussion with CEO Stuart Long of InfoBionic on June 29, 2021, at 10:00 a.m. ET. This event aims to provide shareholders insights into Safeguard's ownership interests and is the fifth in a series led by CEO Eric C. Salzman. Safeguard has invested $22 million in InfoBionic, holding a 25% stake. InfoBionic revolutionizes remote patient monitoring for cardiac services. The discussion can be registered for online and will also be available for later replay.
- None.
- None.
RADNOR, Pa., June 18, 2021 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NYSE:SFE) ("Safeguard" or the "Company") announced that it will host a virtual discussion with Stuart Long, Chief Executive Officer of InfoBionic, Inc. at 10:00 a.m. ET on Tuesday June 29, 2021.
This virtual discussion will be the fifth in Safeguard’s program to provide shareholders with additional information about Safeguard's ownership interests and an opportunity to hear directly from the CEOs of Safeguard’s companies. Eric C. Salzman, CEO of Safeguard, will lead the discussion with Mr. Long.
InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes and cardiac diagnostic services by optimizing clinical and real-world utility for the users that need it most – physicians and their patients.
Safeguard has provided
Mr. Long was appointed CEO of InfoBionic in March 2017, with a focus on driving widespread market adoption of the company’s transformative wireless remote patient monitoring platform for chronic disease management. With more than 20 years of experience in the medical device market, Mr. Long has a proven track record of building organizations to achieve rapid commercial growth and scale. Prior to joining InfoBionic, he was CEO at Monarch Medical Systems, LLC, a Charlotte-based, artificial intelligence clinical decision support software provider for insulin dosing calculations, where he oversaw the organizational transformation of the company.
To attend the virtual discussion, please register at: https://us02web.zoom.us/webinar/register/WN_aAkuVYqbRY2YBSmwmIqYqw
Participants are encouraged to dial-in 15 minutes prior to the start of the event. The virtual discussion will also be accessible for replay later at the Safeguard Scientifics, Inc. Investor Relations website.
Previous virtual discussions with Safeguard companies, meQuilibrium, Flashtalking, Aktana and Prognos Health can be accessed at Safeguard’s investor relations past events site: https://ir.safeguard.com/investors/events-and-presentations/past-events/default.aspx
About Safeguard Scientifics
Historically, Safeguard Scientifics (NYSE:SFE) has provided capital and relevant expertise to fuel the growth of technology-driven businesses. Safeguard has a distinguished track record of fostering innovation and building market leaders that spans more than six decades. Currently, Safeguard is pursuing a focused strategy to value-maximize and monetize its ownership interests over a multiyear time frame to drive shareholder value. For more information, please visit www.safeguard.com.
About InfoBionic
InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. The Massachusetts-based team of seasoned entrepreneurs have had successful careers in healthcare, IT, medical devices and mobile technology, and bring specific expertise in remote monitoring and cardiology. They have seen first-hand the complexities of traditional cardiac arrhythmia detection and monitoring processes and designed the transformative MoMe® Kardia platform to remove the roadblocks hindering faster, more effective diagnosis and decision-making. Frost & Sullivan bestowed the 2019 North American Remote Cardiac Monitoring Technology Leadership Award upon InfoBionic.
Forward-looking Statements
Except for the historical information and discussions contained herein, statements contained in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements are subject to risks and uncertainties. Forward-looking statements include, but are not limited to, statements regarding Safeguard's ability to maximize the value of monetization opportunities of its ownership interests and drive total shareholder returns, Safeguard's initiatives taken or contemplated to enhance and unlock value for all of its shareholders, Safeguard's efforts to execute on and implement its strategy to streamline its organizational structure, reduce its operating costs, pursue monetization opportunities for ownership interests and maximize the return of value to its shareholders, Safeguard's ability to create, unlock, enhance and maximize shareholder value, the effect of Safeguard's management succession plan on driving increased organizational effectiveness and efficiencies, the ability of the management team to execute Safeguard's strategy, the availability of, the timing of, and the proceeds that may ultimately be derived from the monetization of ownership interests, Safeguard's projections regarding the reduction in its ongoing operating expenses, Safeguard's projections regarding annualized operating expenses and expected severance expenses, monetization opportunities for ownership interests, and the amount of net proceeds from the monetization of ownership interests that will enable the return of value to Safeguard shareholders after satisfying working capital needs and the timing of such return of value. Such forward-looking statements are not guarantees of future operational or financial performance and are based on current expectations that involve a number of uncertainties, risks and assumptions that are difficult to predict. Therefore, actual outcomes and/or results may differ materially from those expressed or implied by such forward-looking statements. The risks and uncertainties that could cause actual results to differ materially include, among others, our ability to make good decisions about the monetization of our ownership interests for maximum value or at all and the return of value to our shareholders, our ability to successfully execute on our strategy to streamline our organizational structure and align our cost structure to increase shareholder value, whether our strategy will better position us to focus our resources on the highest-return opportunities and deliver enhanced shareholder value, the ongoing support of our existing ownership interests, the fact that our companies may vary from period to period, challenges to achieving liquidity from our ownership interests, fluctuations in the market prices of our publicly traded holdings, if any, competition, our inability to obtain maximum value for our ownership interests, our ability to attract and retain qualified employees, market valuations in sectors in which our ownership interests operate, our inability to control our ownership interests, our need to manage our assets to avoid registration under the Investment Company Act of 1940, risks, disruption, costs and uncertainty caused by or related to the actions of activist shareholders, including that if individuals are elected to our Board with a specific agenda, it may adversely affect our ability to effectively implement our business strategy and create value for our shareholders and perceived uncertainties as to our future direction as a result of potential changes to the composition of our Board may lead to the perception of a change in the direction of our business, instability or a lack of continuity that may adversely affect our business, and risks associated with our ownership interests, including the fact that most of our ownership interests have a limited operating history and a history of operating losses, face intense competition and may never be profitable, the effect of economic conditions in the business sectors in which Safeguard's companies operate, and other uncertainties described in our filings with the Securities and Exchange Commission. Many of these factors are beyond Safeguard's ability to predict or control. As a result of these and other factors, Safeguard's past operational and financial performance should not be relied on as an indication of future performance. Safeguard does not assume any obligation to update any forward-looking statements or other information contained in this press release.
SOURCE Safeguard Scientifics, Inc.
Related Links
FAQ
What is the date and time of the Safeguard Scientifics virtual discussion with InfoBionic?
Who will be speaking at Safeguard's virtual event?
How much has Safeguard invested in InfoBionic?
What percentage of InfoBionic does Safeguard own?
Where can I register for the Safeguard Scientifics virtual discussion?
